Member Info for Aberdeenman

Is massive, huge market and growing. CEO said on Friday no one really understands why it is on the increase, but is a multi $B market in the US alone, with no generics available, until now (well will be soon).. "Nuformix has entered into an agreement with Fibrofind to conduct pre-clinical development work for its NXP002 programme. Nuformix Chief Executive Officer Dr Dan Gooding commented �We�re extremely lucky to have had the chance to work with Fibrofind since its inception � the quality of its people, knowledge and expertise make it a unique place to study fibrosis. The first phase of our programme has concluded positively in multiple fibrotic conditions and we�re very excited by the results we�ve seen.�" https://nuformix.com/news/nuformix-announces-fibrosis-programme-with-fibrofind/

Fortunately it will matter little what the share bashers write here, as there will be many investors buying who never read BB's. Media coverage and large rise this week will put it well and truly on the radar. World renowned scientists (one of them, their Chief Scientific Advisor, was named in Medicine Maker�s �Top 100 Most Influential Medicine Maker Power List� in April 2015.) More PHD's and Professors involved here than you would see at a graduation ceremony. Their motivation and reward is the exit strategy, as well as bringing life changing medications to the reach of much more of the global population.

If you read everything you will see they are very likely to have a commercial licensing deal sewn up in the next few months. Will be worth several million, and will be for one region with more to follow. Also the deal will involve recurring revenues, most likely, as these deals involve upfront fees plus royalties. Once deal is announced this will move up to next level, my prediction being 20-40p by then.

Doubt whatever the derampers say will have much effect here anyway. This is Main Market, and will attract a different type of investor than the usual AIM retail crowd (although they will try far too late to get in)

Never any problem taking profit Jimbo, and understandable for some after the 13 month lock in. I know quite a few who have cash lined up like myself, but we shall see. With media coverage and a very small free float it will be tough to get some Monday, and if it hits the leader board (I have little doubt) then even more will be buying I would seriously consider keeping a bit in, if this goes as high as it has the potential to do, then you may be very very pleased.

Lets see what this does on Monday then!!

I agree Happy. Shite prophets were so wrong on this one. Who listens to them anyway let alone pay for their drivel.

Having spoken with the CEO at length today there are not many hurdles at all. He said trial should be very straight forward and quick. They are using the same molecules in a different process, so they should be no difference from the existing medication, which have been around a long time, and are very well understood.. The licensing authorities agree with them. Listen on Monday, but you will have missed to boat by afternoon. Many of us on here bought just before suspension, it was difficult to get any decent quantity. Many on here, including myself, will be trying our damnedest to get hold of more at 8:00 am on Monday, and I suspect most of us will be holding those we do get for some time, reducing the freefloat again. Supply and demand means this will fly. And once it gets on the leader board, many more will try get in.

You could also listen to the CEO on Vox on Monday. However if you wait till Monday afternoon to try buy in, it is unlikely you will be able to buy many, and the price should have risen several hundred percent. But hey, wait and find out more. Late bird never gets the worm. Most of us here invested over 13 months ago, we have done a lot of research on this. There is almost no downside, it is a very very clever bunch of people who are doing something that will transform lives, and that of their investors. Simple way to describe First to market generic medicines for multi billion $ market medical conditions. They 'mimic' the existing medications, but get round the original patents, and they have also patented the new generics they are producing. This will be bought out in 18-36 months by either the existing drug makers to protect their market, or by one of their competitors. Target is $1B price tag. Very little overhead, it is the IP that is valuable. Early licensing deals will be done, producing revenue, both upfront and ongoing. Pipeline of patents and new generic medicines coming up Next big one is to tackle Fibrosis (multi $B market, and they will have (again) first generic produced). CEO also said that they will have strong newsflow over the next few months, with price enhancing news. This is not run by AIM sharks, it is main market and run by world renowned scientists. There will be less than 5% of shares trading on Monday as major shareholders have voluntarily locked themselves in for between 9 and 15 months. As those <5% get bought up the free float will reduce more and more Monday morning pushing the price up substantially. The free float could actually be as little as 2.5% There will be media coverage as well Somewhere between 12p and 20p is coming, could be more. Those in earliest get the biggest gains. CEO also stated that most health services in the world will automatically buy generics when available, so as these guys are producing the first generics they have a guaranteed market, and of course an big reason for the existing drug producers to buy Nuformix up to protect their market share. Going to be a fun day on Monday!!

Just email the CEO inner and ask him I spoke with him today. The guys running this outfit are world renowned scientists, I think they know what they are doing.

Find your own info inner You are clutching at straws. All this detail has already been addressed Money already allocated for tests and they are vasty reduced due to the nature of the procees being employed and safety of the original branded drugs. Fast track licensing and therefore commercial exploitation

I asked him about the truals today He said 24 hours with 12 patients then a few days to analyse the data Inner is a bit of a loser here

Please no one buy first thing Monday morning as I want a few million of those 25mil in free float, and the only way I can get them is if you guys all refrain from buying till I am loaded up. I know you will all be happy to oblige :-/

Will be interesting to see what the mm’s open this at on Monday Has to be the most exciting investment I have been in for a long time Difficlt to predict how hight this will go next week, but with such a small free float 20p is a possibility. Once those selling to take profit are done there will be very very little stock available Happy days Well done to all who got some pre suspension And remember shite profits called it a POS investment company with no investment!! Fools

Fly? Ballistic! Once this hits the leader board on Monday it will be on everyone’s radar Also whatch out for media coverage!!

Life changing investment and life changing products

Freefloat likely to be less than 5% initially and decreasing quickly as they get bought up Will rocket on monday Asked the ceo about exit, and whilst he can not make any guarantees he said comparable companies for where NFX will be in 18-36 months are being bought for around 1 billion USD, do the maths!! Also expecting human trials will be more or less a formality, no problems likely. I have a big chunk of cash waiting for 8am Monday

We are in business boys all resolutions passed

I am going to the egm will update later Rememember name chage to nuformix for next week

Supersonic indeed, about 90% of shares closely held Expect minimum 200% rise Monday but could be much much more